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OBJECTIVES: Interest of patients and physicians in celiac disease is growing worldwide, but without a corresponding increase in
the awareness of the disease. Many patients are diagnosed as celiacs even without completing the whole diagnostic process, with
consequent risk of misdiagnosis and delay in the evaluation of other diseases. The objective of this study was to assess the rates
of prior celiac disease misdiagnosis among patients referred to a tertiary care center.
METHODS: From June 2013 to December 2014, we prospectively recruited patients referred for the first time to our Celiac Disease
Center. Patients with a previous diagnosis of celiac disease underwent a diagnostic revaluation by second reading of duodenal
tissue slides, dosage of specific antibodies, and/or duodenal biopsy sampling; HLA status was investigated in pertinent cases.
RESULTS: A total of 198 subjects were recruited. Of these, 91 “naïve” patients (46%) started the diagnostic screening for celiac
disease; 58 of them (64–29% of the whole sample) were diagnosed as celiacs. The remaining 107 patients (54%) came with a
previous diagnosis of celiac disease: of these, 52 (49–26% of the whole sample) presented with confirmed diagnosis of celiac
disease, whereas 55 (51–28% of the whole sample) underwent diagnostic revaluation. After the reassessment, diagnosis was
rejected in 43 cases (78–22% of the whole sample) and confirmed in the remaining 12 (22–6% of the whole sample). Overall,
diagnosis was confirmed in only 64 of the 107 subjects with a previous diagnosis (60–32% of the whole sample). Diagnosis
of celiac disease was more frequently confirmed in “naïve” patients compared those with a questionable previous diagnosis
(64% vs. 22%; Po0.0001).
CONCLUSIONS: A considerable number of patients referred to a tertiary care center are inaccurately diagnosed with celiac
disease. Although we cannot exclude that uncertain diagnosis was a reason for the referral, we suggest greater adherence to
guidelines to minimize the burden of celiac disease misdiagnosis.
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INTRODUCTION
Celiac disease (CD) is a chronic autoimmune disorder of the
small bowel that develops in genetically predisposed subjects.
CD is induced by the ingestion of gluten and triggered by
environmental factors.1 According to the Current Guidelines
by the American College of Gastroenterology2 and by the
British Society of Gastroenterology3 for the diagnosis and
management of CD in adult patients, CD is usually suspected
by the positivity of specific antibody testings (endomysium
antibodies (EMAs), transglutaminase antibodies (tTGs), dea-
midated gliadin antibodies), and the diagnosis is confirmed by
the presence of typical histological features of the duodenal
mucosa. The whole diagnostic process should be carried on a
gluten-containing diet.
Formerly CD was considered a rare condition, with overall
prevalence of 0.03% around 1970s.4 The prevalence of CD
has often been compared with an iceberg,5 whose visible
surface is composed of symptomatic subjects, representing a
small part of the total. Actually, CD is considered a under-
diagnosed disease.6
CD was gradually recognized more often over time, and
currently the estimated mean overall prevalence in western
countries is 1%.7 In the recent past, interest in CD has
gradually increased, not only among clinicians interested in
digestive diseases but also among other specialists—such as
dermatologists and gynecologists—as well as general practi-
tioners, probably because CD is a systemic disease, and may
involve multiple organs.
Moreover, the excitement of media—especially Internet—
towards the harmful properties of gluten and towards gluten-
related disorders (which includes, beyond CD, wheat allergy
and non-celiac gluten sensitivity)8 is growing worldwide.
Therefore, a huge number of individuals exclude gluten from
their diet even in the absence of CD, and gluten-free diet
(GFD) is advocated by several Web forums, patients, and
clinicians as part of a healthy lifestyle, even without any
reliable medical reasons.9 One of the consequences of such a
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trend is that several subjects receive or self-report a diagnosis
of CD, consequently starting a GFD, without completing the
proper diagnostic process recommended by current guide-
lines, and often without any prior medical consultation. Such a
behavior might lead to a considerable waste of resources and
to a significant diagnostic delay both in celiacs and in subjects
without CD.
The Policlinico “Agostino Gemelli” is an academic tertiary
care center, and it is a referral center for gastroenterology and
especially for CD. It is located in Rome, a metropolis with 3
million people. At this hospital, CD is diagnosed, cared for and
followed up, and we accomplish also the certification of the
disease (that, in Italy, is needed to receive gluten-free food
vouchers and health-care tax exemption, and can be
performed only by few empowered centers), as well as the
evaluation of subjects with suspected CD and the manage-
ment of challenging situations, including the reassessment of
previous unclear diagnoses.
During our clinical practice, we had the feeling that the
number of previous diagnoses of CD, which we rejected after
re-evaluation was considerable. Misdiagnosis of CD represents
an incoming but burdensome issue, as already assessed by
retrospective studies performed in tertiary referral centers.10 To
date, however, prospective data on CD misdiagnosis are still
not available.
Our aim was therefore to assess prospectively the rates of
prior CD misdiagnosis among patients referred to a tertiary
care center.
METHODS
Study design. We designed a prospective study aimed to
investigate the rate of prior CD misdiagnosis among patients
referred to our tertiary care center for the diagnosis and
management of CD. Because of the intrinsic aim of the study,
only patients referred to us for the first time were considered for
inclusion, whereas subjects returning at our observation for
follow-up visits were excluded. Only patients older than 18
years were enrolled. After obtaining their informed consent,
enrolled subjects were subdivided into two categories: (a)
“naïve” patients, who came without a prior diagnosis of CD; (b)
patients with a previous diagnosis of CD. The latter group of
patients was critically re-evaluated, to distinguish subjects with
a proper diagnosis from those with a questionable diagnosis,
and to assess the rates of final CD misdiagnosis among them.
The number of patients diagnosed with CDwas assessed in
both study groups. Furthermore, we gathered together all
patients referred to us without a proper diagnosis of CD, which
were, respectively, naïve patients without a prior diagnosis of
CD and patients with a questionable previous diagnosis of CD,
and compared the rates of final CD diagnosis between these
two subgroups.
Criteria for defining proper diagnosis/questionable diag-
nosis/misdiagnosis of CD. According to the main interna-
tional guidelines,2,3 we considered as criteria to diagnose CD
the positivity of EMA and/or tTG associated with any of the
different degrees of Marsh–Oberhuber classification (villous
atrophy, crypt hyperplasia, intraepithelial lymphocytosis).11
Although it shows a good diagnostic accuracy, we did not
include deamidated gliadin antibodies among antibodies
taken into account, as it was proven to be outperformed by
tTG in a recent metanalysis.12 Every diagnosis of CD, which
met these criteria, was considered as a proper diagnosis,
whereas diagnoses that did not meet these criteria were
considered as questionable diagnoses. All previous diag-
noses that were finally rejected after our evaluation were
considered as misdiagnoses of CD.
Criteria for rejecting CD diagnosis. We rejected previous
diagnoses of CD in the presence of at least one of the
following reasons: absence or negativity of EMA/tTG dosage
on gluten-containing diet; absence of histological assess-
ment; unclear histology report; and negativity of HLA-DQ2 or
-DQ8. Data regarding those who diagnosed the disease
(physicians or patients itself) and about the gluten exposure
status (gluten consumption or gluten avoidance) of the
patients at the time of the diagnostic process were also
collected.
Procedures to evaluate or to re-evaluate CD. Naïve
patients referred to us without a prior diagnosis of CD
underwent one or more of the following exams to diagnose
CD: serology assessment (total serum immunoglobulin A
blood test, EMA, tTG); upper endoscopy with duodenal
biopsies. Exams were requested only if they had not been
performed before, were not available at the time of our
examination, or had been performed on GFD.
Among patients with a previous CD diagnosis, when the
diagnosis was questionable, its revaluation was carried out
through one or more of the following procedures: repetition of
serology assessment (total serum immunoglobulin A blood
test, EMA, tTG); second reading of duodenal tissue slides by
two experienced histopathologists (V.A., R.R.); repetition of
duodenal biopsy and subsequent histological evaluation by
the same histopathologists; and assessment of HLA status.
All patients showing positivity of EMA and TTG and typical
histological signs of CD were not requested to perform HLA
testing. Measurement of tTG IgA antibodies was performed by
ELISA (Enzyme-Linked Immunosorbent Assay, automated
system; Delta Biologicals SRL, Rome, Italy), through human
recombinant tTG as antigen; the required threshold for positive
tTG was 10 AU/ml. Assessment of EMA IgAwas performed by
experienced employees, through immunofluorescence analy-
sis on a tissue slide of monkey esophagus (Delta Biologicals
SRL). The required threshold for positive EMA was 1:20. All
exams were performed at our center.
All patients who were following a GFD at the time of our
examination were requested to undergo a minimum 8-week
gluten challenge (with at least 3 g of gluten daily) before the
diagnostic revaluation, as recommended by the American
College of Gastroenterology.2 We collected at least four
biopsies in the second duodenal portion and two biopsies in
the duodenal bulb.2 We took one biopsy per each forcep pass
through the working channel of the endoscope, and immedi-
ately oriented them for the histological assessment. Both
pathologists were blinded to each other during second reading
of duodenal tissue slides as well as during the histological
evaluation of newly repeated duodenal biopsies.
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Statistical analysis. Data were analyzed using the Graph-
Pad Quickcalcs online software (©2014 GraphPad Software,
La Jolla, CA, www.graphpad.com; http://www.graphpad.com/
quickcalcs). We compared categorical data through a 2× 2
contingency table, with Fisher’s exact test. Interobserver
agreement between the two histopathologists (R.R., V.A.)
dealing with second reading of duodenal tissue slides was
calculated with Cohen’s κ-statistics.
RESULTS
From June 2013 to December 2014, a total of 523 patients
attended our outpatient clinic for the diagnosis and manage-
ment of CD. Among these, we recruited for this study 198
patients (males= 50; females=148; mean age=39 years old)
(38%) at their first examination at our center. All enrolled
patients gave their informed consent to participate in the study.
The remaining 325 patients (62%) referred us for follow-up
visits of CD, so they were not considered for inclusion.
“Naïve” patients. Of 198 recruited patients, 91 “naïve”
patients (male=29; female= 62; mean age=34 years old)
(46%) referred us without a previous diagnosis of CD, for one
or more of the following reasons: signs and symptoms
possibly related to the disease (such as gastrointestinal
symptoms, fatigue, iron deficiency anemia), family history of
CD, positivity of EMA and tTG, typical histological pattern of
the duodenum (see details in Table 1). All 91 subjects were
on gluten-containing diet at the time of our evaluation. Fifty-
eight of them (64–29% of the whole sample) fulfilled the
diagnostic criteria and were diagnosed as celiacs; in the
remaining 33 patients (36–16% of the whole sample), the
diagnosis of CD was ruled out. Final diagnoses of patients
with rejected diagnosis of CD are shown in Table 2.
Revaluation of previous CD diagnosis. One-hundred and
seven of the 198 recruited patients (54%) came to our
observation with a previous CD diagnosis, mainly to receive
CD certification (that is required in Italy for obtaining
exemption from payment of gluten-free food) or for a follow-
up visit. Fifty-two of them (49–26% of the whole sample)
presented with confirmed diagnosis of CD, and their follow-up
was scheduled.
The remaining 55 patients (51–26% of the whole sample)
did not meet the standardized diagnostic criteria for CD and
the previous diagnosis was considered questionable. All of
them were already on GFD at the time of our examination, and
underwent gluten challenge before the diagnostic revaluation.
Overall, the gluten challenge period ranged from 3 to 6months
(mean=4 months). Thirty-nine patients (71%) were diag-
nosed with CD by their trusted doctor (gastroenterologist,
gynecologist, dermatologist, or general practitioner), and 16
(29%) patients instead self-diagnosed the disease after an
advice from a friend and/or surfing the Internet. Supportive
evidence for the previous diagnoses of CD is shown in
Table 3a, as well as the reasons we put forward to reject CD
diagnoses. The procedureswe thought necessary for a proper
Table 1 Baseline demographic and clinical characteristics of (1) patients at their
first examination for CD (“naïve” patients) and (2) patients with a previous
diagnosis of CD
Characteristic Patients
(1) “Naïve” patients
No. of patients/mean age (s.d.) 91/34 (±15)
years old
Females/males 29/62 (32%/
68%)
Motivations for suspect of CD (no. of cases—
multiple motivations were possibile in a single
patient)
Iron deficiency anemia 75
Fatigue 35
Gastrointestinal symptoms (bloating, diarrhea,
abdominal pain)
83
Family history of CD 33
EMA and tTG positivity (%) 58 (64%)
IgA deficiency (%) 0 (0%)
Typical duodenal histology pattern (%) 58 (64%)
Marsh 1=7
Marsh 2=10
Marsh 3=41
Final diagnosis of CD (%) 58 (64%)
(2) Patients with previous diagnosis of CD
No. of patients/mean age (s.d.) 107/40 (±12)
years old
Females/males 40/67 (37%/
63%)
Motivations for suspect of CD (no. of cases—
multiple motivations were possibile in a single
patient)
Iron deficiency anemia 85
Fatigue 51
Gastrointestinal symptoms (bloating, diarrhea,
abdominal pain)
100
Family history of CD 29
EMA and tTG positivity (%) 64 (60%)
IgA deficiency (%) 0 (0%)
Typical duodenal histology pattern (%) 64 (60%)
Marsh 1=12
Marsh 2=12
Marsh 3=40
Final diagnosis of CD (%) 64 (60%)
CD, celiac disease; EMA, endomysium antibody; IgG, immunoglobulin G; s.d.,
standard deviation; tTG, transglutaminase antibody.
Table 2 Final diagnoses of patients with rejected diagnosis of CD
Diagnosis Overall Naïve Previous
doubtful diagnosis
Non-celiac gluten sensitivitya 20 5 15
Irritable bowel syndromeb 15 8 7
Functional dyspepsiab 10 5 5
Lactose intolerance 15 7 8
Giardia lamblia infection 2 0 2
Gastritis 14 8 6
Total number 76 33 43
CD, celiac disease; IgE, immunoglobulin E; NCGS, non-celiac gluten sensitivity;
WA, wheat allergy.
aThe diagnosis of NCGS was hypothesized after the exclusion of CD and WA,
when the patient reported the occurrence of symptoms after gluten exposure,
with their improvement/disappearance after gluten withdrawal, and recurrence
after gluten challenge.21 WAwas excluded by dosage of wheat-specific IgE and
skin prick tests.21
bDiagnosed according to the Rome III Criteria.22,23
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diagnostic reassessment of patients are summarized in
Table 3b.
After our revaluation, CD diagnosiswas confirmed only in 12
of the 55 patients with questionable previous diagnosis (22–
6% of the whole sample), whereas it was withdrawn in the
remaining 43 patients (78–22% of the whole sample).
Strikingly, none of the patients coming with the only positivity
of antigliadin antibodies were finally diagnosed with CD. Final
diagnoses of patients with a rejected diagnosis of CD are
shown in Table 2.
Overall, CD diagnosis was confirmed in 64 of the 107
subjects referred to us with a previous diagnosis (60–32% of
the whole sample).
A flow chart of overall patients at different levels of
evaluation is available in Figure 1.
After the accomplishment of the complete diagnostic
process, CD diagnosis was confirmed in 12 of the 55 patients
with a questionable previous diagnosis compared with 58 of
the 91 naïve patients without a previous diagnosis of CD, with
a statistically significant difference between the two groups
(22% vs. 64%; Po0.0001; odds ratio (OR)= 0.16; 95%
confidence interval= 0.07–0.34) (Figure 2). Neither gender
nor age of patients influenced the rates of final CD diagnosis.
Interobserver agreement between two histopathologists
(R.R., V.A.) who reviewed the duodenal tissue slides was
excellent (K=0.91).
DISCUSSION
Formerly, CD was considered a rare pediatric disorder, often
underdiagnosed or diagnosed with significant delay among
adults. A better knowledge of the real prevalence of CD and of
its proper diagnosis was advocated o10 years ago.6 Never-
theless, the increasing awareness of the disease, along with
the widespread diffusion of serology antibody screening and
with the improvement in diagnostic techniques,13 movedCD to
be recognized as a frequent condition. Therefore, CD started
to be commonly investigated among patients with pertinent
gastrointestinal and extraintestinal symptoms, as well as
among relatives of celiacs. The current estimated prevalence
of CD among European adults is about 1%.7 The disease
remains still underdiagnosed in several categories of patients
(above all, elderly population and patients presenting with
non-classical or asymptomatic CD). Notwithstanding, the
overestimation of CD prevalence in general population has
been claimed.14 The number of inconsistent diagnoses is
increasing continuously, and represents a real issue for routine
clinical practice; furthermore, it is associated with unneces-
sary expenses related to the exemptions for gluten-free food
and to the performance of diagnostic exams.15 Current
Guidelines by the American College of Gastroenterology2
and the British Society of Gastroenterology3 recommend that
CD should be detected by dosage of specific serum
antibodies, and diagnosis should be confirmed by upper
endoscopy and duodenal biopsies; patients should keep to a
gluten-containing diet during the whole diagnostic process.
In the present study, we found that, among patients referred
to us with a questionable previous diagnosis of CD, only 22%
(n=12) of them were confirmed to be celiacs, whereas the
diagnosis was rejected in 78% of them (n=43). Diagnosis of
CDwasmore frequently confirmed in “naïve” patientswithout a
prior diagnosis of CD compared with those with a questionable
previous diagnosis (64% vs. 22%; Po0.0001) (Figure 2).
Overall, CD diagnosis was confirmed only in 64 of the 107
subjects referred to us with a previous diagnosis (60–32% of
the whole sample). This is surprising, especially if we consider
that rates of CD diagnosis among naïve patients were slightly
higher (58 patients –64–29% of the whole sample).
Thirty-nine of 55 patients were first diagnosed with CD by
other physicians, including gastroenterologists, gynecolo-
gists, dermatologists or general practitioners. We questioned
the previous diagnoses for several reasons, including absence
or negativity of specific antibodies (EMA and tTG), unclear
histological report, and even the absence of duodenal biopsy
and negativity of HLA-DQ2/-DQ8.
In particular, 13 patients were previously diagnosed as
celiacs because of the positivity of native antigliadin antibodies,
which have been dismissed long ago for the diagnosis of CD,
and are no longer recommended by international guidelines,2,3
because of the high variability in their diagnostic accuracy.16
These results suggest that a considerable number of
physicians are not aware of the current diagnostic criteria for
CD. As CD is a systemic disease, and can present with
gastrointestinal as well as extraintestinal symptoms, different
consultants could be involved in the management of the
Table 3a Supportive evidence for previous CD diagnoses in the 55 patients with
doubtful diagnosisa
Supportive evidence for previous CD
diagnosis
No. of patients/% of
patients
Positivity of serum antibodies 17 (AGA= 13; EMA= 4b;
tTG=4b)/31%
Suggestive histological features 20/36%
Positivity of HLA-DQ2 or HLA-DQ8 26/47%
Amelioration of symptoms after GFD 16/29%
Supportive evidence for contesting
previous CD diagnosis
No. of patients/% of
patients
Negativity or absence of EMA and/or tTG 51/93%
Duodenal biopsy not performed 35/64%
Unclear histology features 20/36%
Negativity of HLA-DQ2 or -DQ8 2/4%
AGA, antigliadin antibody; CD, celiac disease; EMA, endomysium antibody;
tTG, transglutaminase antibody.
aMultiple evidences were possible in a single patient.
bSame patients.
Table 3b Diagnostic procedures performed for the revaluation of previous
doubtful diagnosesa
Diagnostic procedures No. of patients
Dosage of EMA and/or tTG (n= 102) EMA=51; tTG=51
Upper endoscopy and duodenal biopsies
(n=35)
35
Second reading of duodenal tissue slides
(n=20)
20
Search of HLA-DQ2 or -DQ8 (n=2) 2
EMA, endomysium antibody; tTG, transglutaminase antibody.
aMultiple procedures were possible in a single patient.
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disease, also at the beginning of the diagnostic process, and
should be confident with the proper flow chart for the
investigation of CD. More strikingly, almost a third of patients
(29%) presented us with a self-diagnosed disease, after an
advice from a friend and/or surfing theWeb, without consulting
any physician. Such a phenomenon is not unfrequent,17 and
probably has been increased by the expanding widespread
access to the Web.18
All 55 patients with a doubtful diagnosis of CD were already
on GFD at the time of the examination. Such results could
have been influenced by the increasing diffusion of GFD also
among patients without CD. GFD represents the primary
treatment for uncomplicated CD, and is mandatory for CD
patients. Notwithstanding, a considerable part of individuals
embraceGFD in the absence of CD, or even without searching
for CD and without any prior medical consultation.8 As a
consequence, US gluten-freemarket is increasing since 2008,
reaching more than US$2.5 billion volume in 2010.19
This is not the first study assessing the rate of misdiagnosis
among patients referred to a tertiary care center for CD. In
2009, Pinto-Sanchez et al.20 described a considerable rate of
overdiagnosis of CD in a setting of community medicine,
primarily because of histological misdiagnosis. In a 9-year
retrospective study, Biagi et al.10 questioned CD diagnosis in
180 of 614 patients, confirming CD in only 61 of them (29.5%).
One hundred and seventeen patients (65%) were on GFD at
the time of authors’ examination. Compared with previous
reports, we found higher percentages of people being on GFD
at the time of the examination, but lower rates of confirmed CD
diagnoses. These findings may reflect that both patients and
physicians increased their interest in CD over the past few
years, but that this excitement was not associated with a
corresponding increase in the awareness of the proper
diagnostic process of the disease.
Figure 1 Flow chart of overall patients at different levels of evaluation.
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Figure 2 Rates of CD diagnosis confirmation in patients with a questionable
diagnosis and in “naïve” patients. CD, celiac disease.
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In conclusion, our study shows that a considerable number
of patients referred to a tertiary care center experience
previous misdiagnosis and/or overdiagnosis of CD. Greater
accuracy in the application of the proper diagnostic process
and closer adherence to guidelines are needed to minimize
the burden of CD misdiagnosis.
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Study Highlights
WHAT IS CURRENT KNOWLEDGE
✓ Currently, misdiagnosis of celiac disease (CD) represents
an incoming but burdensome issue.
✓ Prospective data on misdiagnosis are still not available.
WHAT IS NEW HERE
✓ Our results show that a considerable number of patients
referred to a tertiary care center are inaccurately diagnosed
with CD.
✓ CD was confirmed in only 60% of subjects referred to our
center with a previous diagnosis of the disease.
✓ Diagnosis of CD was more frequently confirmed in “naïve”
patients compared with those with a questionable previous
diagnosis.
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